ArticleFrontiers in plant science2025
Identification of yellow vein clearing disease in lemons based on hyperspectral imaging and deep learning.
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrating scanning electron microscopy, explainable deep learning, and ITS sequencing for accurate identification in some species Geastrum.Scientific reports · 2026Article
- Spectral image classification of asymptomatic peanut leaf diseases based on deep learning algorithms.Plant methods · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyperspectral imaging (HSI) technology has great potential for the efficient and accurate detection of plant diseases. To date, no studies have reported the identification of yellow vein clearing disease (YVCD) in lemon plants by using hyperspectral imaging. A major challenge in leveraging HSI for rapid disease diagnosis lies in efficiently processing high-dimensional data without compromising classification accuracy. In this study, hyperspectral feature extraction is optimized by introducing a novel hybrid 3D-2D-LcNet architecture combined with three-dimensional (3D) and two-dimensional (2D) convolutional layers-a methodological advancement over conventional single-mode CNNs. The competitive adaptive reweighted sampling (CARS) and successive projection algorithm (SPA) were utilized to reduce the dimensionality of hyperspectral images and select the feature wavelengths for YVCD diagnosis. The spectra and hyperspectral images retrieved through feature wavelength selection were separately employed for the modeling process by using machine learning algorithms and convolutional neural network algorithms (CNN). Machine learning algorithms (such as support vector machine and partial least squares discriminant analysis) and convolutional neural network algorithms (CNN) (including 3D-ShuffleNetV2, 2D-LcNet and 2D-ShuffleNetV2) were utilized for comparison analysis. The results showed that CNN-based models have achieved an accuracy ranging from 93.90% to 97.35%, significantly outperforming machine learning approaches (ranging from 68.83% to 93.52%). Notably, the hybrid 3D-2D-LcNet has achieved the highest accuracy of 97.35% (CARS) and 96.86% (SPA), while reducing computational costs compared to 3D-CNNs. These findings suggest that hybrid 3D-2D-LcNet effectively balances computational complexity with feature extraction efficacy and robustness when handling spectral data of different wavelengths. Overall, this study offers insights into the rapidly processing hyperspectral images, thus presenting a promising method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.